- Home
- IFRX vs PRPL Comparison
IFRX vs PRPL Comparison
Compare IFRX & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- PRPL
- Stock Information
- Founded
- IFRX 2007
- PRPL 2010
- Country
- IFRX Germany
- PRPL United States
- Employees
- IFRX N/A
- PRPL N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- PRPL Home Furnishings
- Sector
- IFRX Health Care
- PRPL Consumer Discretionary
- Exchange
- IFRX Nasdaq
- PRPL Nasdaq
- Market Cap
- IFRX 117.8M
- PRPL 96.8M
- IPO Year
- IFRX 2017
- PRPL N/A
- Fundamental
- Price
- IFRX $1.00
- PRPL $0.65
- Analyst Decision
- IFRX Strong Buy
- PRPL Hold
- Analyst Count
- IFRX 2
- PRPL 2
- Target Price
- IFRX $9.00
- PRPL $1.25
- AVG Volume (30 Days)
- IFRX 322.6K
- PRPL 1.4M
- Earning Date
- IFRX 05-07-2025
- PRPL 05-06-2025
- Dividend Yield
- IFRX N/A
- PRPL N/A
- EPS Growth
- IFRX N/A
- PRPL N/A
- EPS
- IFRX N/A
- PRPL N/A
- Revenue
- IFRX $171,642.00
- PRPL $487,877,000.00
- Revenue This Year
- IFRX $106.72
- PRPL N/A
- Revenue Next Year
- IFRX $66.89
- PRPL $5.62
- P/E Ratio
- IFRX N/A
- PRPL N/A
- Revenue Growth
- IFRX 162.79
- PRPL N/A
- 52 Week Low
- IFRX $1.01
- PRPL $0.65
- 52 Week High
- IFRX $2.82
- PRPL $2.12
- Technical
- Relative Strength Index (RSI)
- IFRX 33.87
- PRPL 35.38
- Support Level
- IFRX $1.01
- PRPL $0.71
- Resistance Level
- IFRX $1.18
- PRPL $0.84
- Average True Range (ATR)
- IFRX 0.12
- PRPL 0.06
- MACD
- IFRX 0.01
- PRPL -0.01
- Stochastic Oscillator
- IFRX 3.66
- PRPL 0.00
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its lead product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms, and other products. It sells its products through online channels, traditional wholesale partners and third-party online retailers.